FDA adcomm reform talks heat up

Controversies have battered the FDA’s credibility around drug approvals in recent years, and the agency is mulling reforms that reflect changing times.

The revamp isa project of commissioner Dr. Robert Califfhas lobbied for over the past few years, arguing that adcomms could do away with voting on approval recommendations to help eliminate confusion about their role in the regulatory process.